First Eagle Value in Biotechnology Fund (QP), LP — Form D/A
First Eagle Value in Biotechnology Fund (QP), LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2018-03-13. $68.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-03-13
- Form: D/A
- Accession: 0000919574-18-002434
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $68.2M
- Minimum investment: $1.0M
- Investors: 65
- Date of first sale: 2005-09-15
- Security types: equity, fund interests
- SEC file number: 021-139441
Issuer
- Name: First Eagle Value in Biotechnology Fund (QP), LP
- CIK: 0001481559
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: FIRST EAGLE INVESTMENT MANAGEMENT, LLC, NEW YORK, NY, 10105
- Phone: 212-698-3300
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| -- -- First Eagle Investment Management, LLC | Executive Officer | New York, NY |
| Tim -- Tabor | Executive Officer | New York, NY |
| Tim Tabor | Executive Officer | NEW YORK, NY |
Other filings by this issuer (8)
More